Sabra Health Care REIT, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 84.21 million compared to USD 85.37 million a year ago. Revenue was USD 140.76 million compared to USD 128.59 million a year ago. Net loss was USD 50.06 million compared to net income of USD 10.22 million a year ago. Basic loss per share from continuing operations was USD 0.22 compared to basic earnings per share from continuing operations of USD 0.05 a year ago. Diluted loss per share from continuing operations was USD 0.22 compared to diluted earnings per share from continuing operations of USD 0.05 a year ago.
For the nine months, sales was USD 297.27 million compared to USD 309.53 million a year ago. Revenue was USD 459.83 million compared to USD 433.89 million a year ago. Net income was USD 7.34 million compared to net loss of USD 88.9 million a year ago. Basic earnings per share from continuing operations was USD 0.03 compared to basic loss per share from continuing operations of USD 0.41 a year ago. Diluted earnings per share from continuing operations was USD 0.03 compared to diluted loss per share from continuing operations of USD 0.41 a year ago.